Michifumi Yamashita

12PUBLICATIONS
55CO-AUTHORS
Molecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)MechanobiologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 18, 2026
Renal tubule-specific Nrf2 deletion ameliorates diabetic kidney disease by attenuating glomerular hypertension and kidney injury in a mouse model of diabetes.

|Sep 05, 2025
PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.

Shen Yang, Eugenio Santelli, Carlos G Gonzalez

|Jun 17, 2025
Adverse functions of neutrophils are regulated by neutrophilic angiotensin-converting enzyme in immune complex-mediated crescentic glomerulonephritis.

Suguru Saito, Satoshi Kumakura, Zakir Khan

|Jun 11, 2025
Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome.

Kana N Miyata, Denise M Smith, Michifumi Yamashita

|Feb 22, 2024
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys.

Shikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco

|Sep 21, 2022
Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery.

Ken Hiratsuka, Tomoya Miyoshi, Katharina T Kroll

Pageof 2

Frequent Collaborators

3 joint publications

Kana N Miyata

3 joint publications

Shao-Ling Zhang

3 joint publications

John S D Chan

2 joint publications

Ryuji Morizane